Who
Martina Flammer
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Insmed.
In numbers
- Trades disclosed
- 244
- Buys
- 0
- Sells
- 55
- Bought
- $0
- Sold
- $102.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Jan 2020
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $346K18,278 at $18.95 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $230K8,895 at $25.83 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $1.1M8,895 at $127.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,278 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,895 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $2.4M18,278 at $129.40 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,278 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,895 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $346K18,278 at $18.95 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $230K8,895 at $25.83 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $1.1M8,895 at $127.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $2.4M18,278 at $129.40 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $231K7,945 at $29.13 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $86K4,357 at $19.74 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $529K4,854 at $109.02 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,945 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,357 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $824K7,448 at $110.60 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,945 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,357 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.